Suven Pharmaceuticals Limited (SUVENPHAR) — Working Capital to Net Assets Ratio
Suven Pharmaceuticals Limited (SUVENPHAR) has a Working Capital to Net Assets ratio of 28.4% as of March 2025. Working capital of Rs5.23 Billion (current assets of Rs8.89 Billion minus current liabilities of Rs3.65 Billion) is measured against net assets of Rs18.41 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Suven Pharmaceuticals Limited (SUVENPHAR) flexibility index to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Suven Pharmaceuticals Limited Working Capital to Net Assets (2019–2025)
This chart shows how Suven Pharmaceuticals Limited's Working Capital to Net Assets ratio has evolved across 7 annual periods from 2019 to 2025. As of March 2025, the ratio stands at 28.4%, reflecting working capital of Rs5.23 Billion against net assets of Rs18.41 Billion INR. See SUVENPHAR days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Suven Pharmaceuticals Limited (2019–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Suven Pharmaceuticals Limited from 2019 to 2025, covering 7 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see SUVENPHAR market cap.
| Year | WC/NA Ratio | Working Capital (INR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 28.4% | Rs5.23 Billion | Rs18.41 Billion | Rs8.89 Billion | Rs3.65 Billion | ▼ -28.0 pp |
| 2024 | 56.4% | Rs11.56 Billion | Rs20.51 Billion | Rs12.63 Billion | Rs1.07 Billion | ▲ +7.3 pp |
| 2023 | 49.1% | Rs8.52 Billion | Rs17.35 Billion | Rs10.11 Billion | Rs1.59 Billion | ▼ -11.0 pp |
| 2022 | 60.1% | Rs9.18 Billion | Rs15.27 Billion | Rs11.28 Billion | Rs2.10 Billion | ▲ +30.9 pp |
| 2021 | 29.2% | Rs3.45 Billion | Rs11.81 Billion | Rs5.65 Billion | Rs2.20 Billion | ▲ +6.6 pp |
| 2020 | 22.6% | Rs1.91 Billion | Rs8.45 Billion | Rs3.92 Billion | Rs2.00 Billion | ▼ -16.7 pp |
| 2019 | 39.3% | Rs2.32 Billion | Rs5.90 Billion | Rs3.90 Billion | Rs1.58 Billion | — |